- N10, ITTC building, Tamar Science Park, Drake Circus, Plymouth, Devon, PL4 8AA
- sanne.vankampen@plymouth.ac.uk
Profiles
Dr Sanne Van Kampen
Research Fellow
Clinical Trials & Health Research - Institute of Translational & Stratified Medicine (Faculty of Medicine and Dentistry)
Role
PenCLAHRC Research Fellow
Sanne joined the Community and Primary Care Research Group in January 2016 to support various projects in health services research under the PenCLAHRC programme. Her areas of expertise include study design and quantitative analysis. Before joining the University of Plymouth, she worked for KNCV Tuberculosis Foundation and the World Health Organization as technical consultant on tuberculosis diagnostics, where she supported various countries in Africa, Central Asia and South East Asia with the implementation and evaluation of new laboratory methods. Her previous research includes patient cohort trials, cost-effectiveness studies, multi-country surveys and systematic reviews on new approaches for infectious disease control.
Qualifications
Sanne has a background in international public health and infectious diseases. Her PhD thesis evaluated the implementation of new diagnostics for tuberculosis in high-burden countries with the aim to bridge the gap between global policy and local practice. (http://dare.uva.nl/document/2/165754)
MSc Epidemiology, London School of Hygiene and Tropical Medicine (DL ongoing)
PhD Medical Sciences, Universiteit van Amsterdam, 2015
MSc Biomedical Sciences, VU University of Amsterdam, 2010
BSc Biomedical Sciences, Universiteit van Amsterdam, 2007
Key publications are highlighted
Journals
Articles
2017
'The comparative diagnostic accuracy of the Mini Mental State Examination (MMSE) and the General Practitioner assessment of Cognition (GPCOG) for identifying dementia in primary care: a systematic review protocol'
Diagnostic and Prognostic Research
1,
(1)
, DOI
PEARL
2015
'Correction: Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study'
PLOS ONE
10,
(8)
e0136368-e0136368
, DOI
2015
'Effect of introducing Xpert MTB/RIF to test and treat individuals at risk of multidrug-resistant tuberculosis in Kazakhstan: a prospective cohort study'
PLoS One
, DOI
2015
'Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study'
PLOS ONE
10,
(6)
e0123536-e0123536
, DOI
2013
'GeneXpert for TB diagnosis: planned and purposeful implementation'
Global Health: Science and Practice
1,
(1)
18-23
, DOI
2013
'Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis'
PLoS ONE
8,
(12)
e82786-e82786
, DOI
2012
'Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review'
PLoS Medicine
9,
(12)
e1001358-e1001358
, DOI
2012
'Survey of the Diagnostic Retooling Process in National TB Reference Laboratories, with Special Focus on Rapid Speciation Tests Endorsed by WHO in 2007'
PLoS ONE
7,
(8)
e43439-e43439
, DOI
2011
'Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis'
PLoS Medicine
8,
(11)
e1001120-e1001120
, DOI
2010
'Retooling National TB Control Programmes (NTPs) with New Diagnostics: The NTP Perspective'
PLoS ONE
5,
(7)
e11649-e11649
, DOI
2010
'The realistic performance achievable with mycobacterial automated culture systems in high and low prevalence settings'
BMC Infectious Diseases
10,
(1)
, DOI